Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Am J Surg. 2020 Jun 13;220(3):566–579. doi: 10.1016/j.amjsurg.2020.04.041
Study Number of Patients BMI (kg/m2) at Bariatric Surgery (Mean and standard deviation, except as indicated) BMI at Last Follow-up (kg/m2) (Mean and standard deviation, except as indicated) Waitlisted (%) Transplanted (%) Clinical Improvement Precluding Need for Listing Months from Bariatric Surgery to Transplant (Mean and standard deviation, except as indicated) Months of Follow- up After Bariatric Surgery (Mean and standard deviation, except as indicated)
Heart Failure
Amro 1 50 44 NR NR NR NR 6
Caceres 1 37.4 29 1 (100%) 1 (100%) NR 10 22
Chaudhry 6 47.6 (SD 3.0)* NR* 4 (66.7%) 0 (0%) 1 of 6 NR median 22 (range 12–70)*
DeNino 1 50 30.4 1 (100%) 1 (100%) NR 13 16
Gill 2 46.6, 43.7 34.7, 38.5 0 (0%) 0 (0%) NR NR 5, 14
Greene 3 52.3 (SD 2.5) 29.7 (SD 3.2) 2 (66.7%) 2 (66.7%) 0 of 3 17, 24 43.7 (SD 12.0)
Hawkins 11 mean 45.2 (range 39–58)* mean 33.1 (range 26–39)* 7 (63.6%) 4 (36.4%) NR median 12 (range 5–44)* median 12 (range 6–39)*
Jeng 1 40 32 1 (100%) 1 (100%) NR 7 71
Lim 7 43.3 (SD 5.0) 32.4 (SD 4.2) 4 (57.1%) 2 (28.6%) 3 of 7 NR 21.7 (SD 16.5)
Lockard 2 48.8, 52.2 38.6, 40.8 1 (50.0%) ^ 1 (50.0%) NR 18 NR, 24
McCloskey 14 50.8 (SD 7.6) 37.1 (SD 7.2) 2 (14.3%) 2 (14.3%) NR 6, 8 6.7 (SD 2.2)
Punchai 7 44.3 (SD 6.4) 35.0 (SD 7.9) 3 (42.8%) 3 (42.8%) NR 17.7 (SD 5.7) 20.6 (SD 24.2)
Ramani 12 53 (SD 7.0) 47 (SD 4.0) 2 (16.7%) 1 (8.3%) NR NR NR
Ristow 2 43, 56 23, 37 2 (100%) 0 (0%) 2 of 2 NR 24, 24
Saeed 1 41.6 41 1 (100%) 1 (100%) 0 of 1 13 21
Samaras 2 42, 40 31.2, 34.7 1 (50.0%) 1 (50.0%) 1 of 2 13 12, 13
Shah 4 49.2(SD 5.9) 5.5 (4.6) 2 (50.0%) 1 (25.0%) NR 9 7.0 (SD 2.3)
Taylor 1 48.6 28.5 1 (100%) 1 (100%) NR 19 25
Wikiel 4 47.7 (SD 4.4) 35.3 (SD 4.1) 3 (75.0%) 3 (75.0%) NR 13.3 (SD 4.7) 48.5 (SD 42.1)
TOTAL 82 48.4 (SD 6.6) 37.1 (SD 5.8) 33 (40.2%) 24 (29.3%) 7 (8.5%) 13.9 (SD 5.4) 21.8 (SD 22.2)
End-Stage Lung Disease
Ardila-Gatas 25 median 39 (IQR 37–44)* median 30 (IQR 25–36)* 6 (24%) 1 (4%) 3 (12%) 88 NR
Martin 1 37 <30* 0 (0%)** 0 (0%)** 1 (100%) N/A 5
Takata 2 46 (4.5) NR* 2 (100%) 1 (50%) 0 (0%) NR 12.5 (SD 0.7)
TOTAL 28 42.7 (5.4) -- 8 (28.6%) 2 (7%) 4 (14.3%) 88 10 (SD 4.3)
Cirrhosis
Reached BMI<40 kg/m2 by 6 Months Reached BMI<40 kg/m2 by 12 Months
Garcia-Sesma 8 6 (of 7; 85.7% 6 (75.0%) 2 (25.0%) 2 (25.0%) -- 7, 8 33.2 (SD 23.6
Sharpton 32 13 (of 22; 59.1% 20 (62.5%) 21 (65.6%)* 14 (43.7%) 9 (28.1%) median 22 (IQR 1488)** --
Taneja 1 1 (100%) 1 (100%) 1 (100%) 1 (100%) 0 (0%) 12 12
TOTAL 41 20 (of 30; 66.7%) 27 (65.8%) 24 (58.5%) 17 (41.5%) 9 (of 33; 27.3%) 9.0 (SD 2.6) 30.9 (23.2)
Chronic Kidney Disease
BMI (kg/m2) at Bariatric Surgery BMI (kg/m2) at Last Follow-up
Adani 3 NR* NR* 2 (67%) 2 (67%) -- NR* NR*
Al Sabah 1 42 31.5 1 (100%) 1 (100%) -- 29 6
Al Bahri 16 47.5 (SD 7.5) 30.9 (6.4) 4 (25%) 9 (56%) -- 53.2 (SD 16.3) 42.0 (32.8)
Alexander 41 48 (SD NR)* NR* 9 (22%) 9 (22%) -- NR NR*
Buch 1 NR* NR* 1 (100%) 1 (100%) -- 24 NR*
Carandina 9 47.0 (SD 7.1) 33.6 (7.4) 1 (11%) 5 (56%) -- 21 15.7 (10.6)
Contreras-Villamizar 1 42 28.6 0 (0%) 1 (100%) -- No transplant 12
Jamal 21 47.1 (SD 5.5) 35.3 (8.4) 2 (10%) 18 (86%) -- NR 27.6 (22)
Kienzl-Wagner 8 38.8 (SD 3.8) 30.7 (6.0) 7 (88%) 8 (100%) -- 17.6 (SD 10.5) 38.4 (16.8)
Kim 100 43.4 (SD 5.9) 36.9 (5.7) 19 (19%) 19 (19%) -- NR NR*
Koshy 3 40.7 (SD 4.9) 37.2 (1.9) 3 (100%) 3 (100%) -- NR 13.7 (1.2)
Lin 6 NRBO* NRBO* 1 (17%) 6 (100%) -- NRBO NR*
MacLaughlin 9 median 44.2* median 34.7 (range 29.2 – 38.8)* 0 (0%) 3 (33%) -- No transplant 12*
Marszalek 1 41.5 29 1 (100%) 1 (100%) -- 10 10
Newcombe 3 44.6 (SD 5.5) 33.8 (5.0) 3 (100%) 3 (100%) -- 16.3 (SD 10.2) 16.3 (8.3)
Proczko 3 39.9 (SD 2.1) 31.1 (2.4) 1 (33%) 3 (100%) -- 3 3 (0)
Takata 7 49.9 (SD 5.7) NR* 0 (0%) 7 (100%) -- No transplant NR*
Thomas 31 43.5 (SD 0.7) 28.1 (SD 0.8) 14 (67%) 25 (81%) -- median 33* NR*
Yemeni 24 41.5 (SD 0.8) 29 (SD 1.3) 16 (67%) 21 (88%) -- 18 (1 – 51.6)* 47.0 (6.5)
TOTAL 288 44.0 (5.5) 33.7 (5.3) 85 (30%) 145 (50%) -- 24.8 (14.2) 32.9 (21.4)